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Preface 
“Harm reduction” is often made an unnecessarily controversial issue as if there was a contradiction 
between prevention and treatment on one hand and reducing the adverse health and social 
consequences of drug use on the other. This is a false dichotomy. They are complementary.   
Inspired by the international drug control treaties and supported by a growing body of scientific and 
medical evidence, this paper, prepared by the United Nations Office on Drugs and Crime in 
consultation with the International Narcotics Control Board, outlines a comprehensive set of 
measures designed to prevent drug abuse, facilitate entry into drug treatment, and reduce the 
adverse health and social consequences of drug abuse. Such an approach is used for other 
diseases, so why not for curing drug addiction?  
The measures outlined in this paper are inclusive enough to bring back into society all those 
affected by drug addiction, even the most marginalized. It proposes not only health protection 
measures, but also access to high quality clinical facilities to stop or reduce addiction.  
Such an approach can decrease the danger of drugs to the health of individuals and society.  
 
 
Antonio Maria Costa 
Executive Director 
United Nations Office on Drugs and Crime 
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Reducing adverse health and social consequences of drug abuse: 
A comprehensive approach 
 
 
 
 
1. Conceptual and legal framework  
 
 Illicit use of psychoactive drugs is dangerous for the health of individuals and society.  It 
induces changes in behaviour and emotional status and could cause severe psychological 
disorders.  It also undermines the social fabric of the community. Because of their action on the 
brain such drugs are able to induce dependence, leading to loss of interest in many areas of 
life. Drugs are placed under national and international control to prevent the negative health 
and social consequences of substance abuse.  
  
 The Single Convention of 1961 specifies that the “Parties shall give special attention to and 
take all practicable measures for the prevention of abuse of drugs and for the early 
identification, treatment, education, after-care, rehabilitation and social reintegration of the 
persons involved”. 
  
 As stated in article 38 of the 1961 Convention, medical care of drug abusers may include all the 
tools required to treat the adverse health consequences of substance abuse. The 1988 UN 
Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (article 14 
paragraph 4) indicates that “parties to the Convention shall adopt appropriate measures aimed 
at eliminating or reducing illicit demand for narcotic drugs and psychotropic substances, with a 
view to reducing human suffering…which includes interventions to counteract the social and 
health consequences of drug abuse”.  
  
 The International Narcotics Control Board (INCB) acknowledged, already in 1993i, that harm 
reduction has a role to play in a tertiary prevention strategy for demand reduction purposes. 
However, the Board pointed out that while harm reduction programmes can play a part in a 
comprehensive drug demand reduction strategy, they should not be carried out at the expense 
of – or considered substitutes for – other important activities designed to reduce the demand 
for illicit drugs, for example drug abuse prevention activities.  
  
 Education programmes must be carefully designed in order to avoid being counterproductive. 
Support may be given to mass media campaigns to raise public awareness concerning the 
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danger of drug abuse. The principal target group for education programmes is young people 
both in and out of school. Programmes for the promotion of a healthy lifestyle that incorporate a 
drug prevention element should be encouraged. It must be kept in mind that in many 
developing countries with inadequate healthcare and social care services, education 
programmes are practically the only medium available for demand reduction activities.  
  
 In 1998, the UN General Assembly adopted the Declaration on the Guiding Principles of Drug 
Demand Reduction which emphasizes that demand reduction programmes should cover all 
areas of prevention, from discouraging initial use to reducing the negative health and social 
consequences of drug abuse for the individual and society as a whole. 
  
 It is also appropriate to highlight that the INCB, in its 2003 report,i noted that “Governments 
needed to adopt measures that may decrease the sharing of hypodermic needles among 
injecting drug abusers in order to limit the spread of HIV/AIDS”. At the same time, the INCB 
stressed that such measures should not promote and/or facilitate drug abuse. The same report 
also observes that “many Governments have opted in favour of drug substitution and 
maintenance treatment” and that “the implementation of this treatment does not constitute any 
breach of treaty provisions, whatever substance may be used for such treatment in line with 
established national sound medical practice.”  
 
 
2.  Adverse health and social consequences of drug abuse
 
 Dependence on drugs has enormous costs for society in terms of direct and indirect health and 
social consequences: human and financial resources lost due to abuse in the workplace; road 
and domestic accidents related to drug abuse; health care costs related to diseases that 
develop in relation to drug dependence (HIV, Hepatitis and other diseases including mental 
disorders); and social problems including drug-related crimes and deaths due to overdose. The 
majority of these costs are difficult to quantify, but the few available studies indicate that a 
direct correlation exists.  
  
 In the last 25 years, one of the most visible negative consequences of drug dependence has 
been the spread of HIV/AIDS and it is estimated that more than 10% of all HIV infections 
worldwide are due to the use of contaminated drug injecting equipment. If Sub-Saharan Africa 
and the Caribbean are excluded, this rate of injecting drug users rises as high as 30- 40% 
among those with HIV infection. Among injecting drug users, the rate of hepatitis infection in 
some places is even higher than HIV.  
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 Despite the size of the problem and the enormous costs related to drug abuse, in many 
countries specialized services are not available or, if present, are not accessible. There are a 
number of obstacles for drug abusers to access effective services, partly due to stigma and 
discrimination towards those who are drug abusers and HIV positive.  
  
 Although treatment and rehabilitation interventions are being expanded (as reported by 
Member States to UNODC through the Biennial Reports Questionnaire), they are still well 
below the amount and quality that is needed. Detoxification remains the most common 
intervention, with substitution treatment being the least covered in most regions. Interventions 
for reducing the adverse health and social consequences of drug abuse have registered a 
strong increase at the global level and have overtaken treatment and rehabilitation 
interventions in terms of activities reported. In some regions, this trend appears to be 
associated with efforts to prevent the spread of HIV and other infections among injecting drug 
users. However, very few States reported that they were providing a comprehensive set of 
measures for HIV/AIDS prevention and care and even less reported high levels of coverage. 
 
 
3.  Policy recommendations 
 
 UNODC's work in relation to reducing the adverse health and social consequences of drug 
abuse (e.g. HIV prevention) is guided mainly by seven policy documentsii which clearly set out 
that success in reducing the adverse consequences of drug abuse and halting the epidemic of 
blood-borne diseases requires a three part strategy:  
 
3.1 Preventing drug abuse; 
3.2 Facilitating entry into drug dependence treatment;  
3.3 Establishing effective measures to reduce adverse health and social consequences of 
drug abuse.  
 
3.1 Preventing drug abuse; 
 The most important aspect of this strategy is to prevent drug abuse with evidence-based 
measures. The basic message is that not taking drugs is the best way of avoiding the 
negative health and social consequences associated with drug use. This is the most 
effective strategy for protecting vulnerable groups from developing dependence on 
harmful psychotropic drugs. Also unprotected sex has been found to be significantly 
associated to drug abuse because of the lack of behavioural control induced by 
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psychoactive drugs, whether injected or non-injected. Similarly, for example car accidents, 
involvement in violent and unlawful behaviour, accidents in work places, suicide and 
overdoses can be significantly reduced, with decreased harm for individuals and society, if 
drug abuse is reduced. 
 
3.2 Facilitating entry into drug dependence treatment;  
For those who are using drugs, providing accessible, evidence-based, good practice 
treatment for drug abusers and drug dependent individuals has been found to reduce 
individual and social harm. The option of drug-free oriented treatment, or at least the 
possibility to reduce illicit drug use, as well as retention in treatment with continuous 
contacts with health care providers, have proved effective in reducing overdoses, 
infections, car accidents, legal problems, criminal behaviour, psychiatric hospitalizations 
and suicide rates. This has been demonstrated for both pharmacologically assisted 
treatment (long acting opioid-agonists and use of antagonists) and drug-free oriented 
treatments.  Differentiated and targeted treatment should be available for specific sub-
groups of drug dependent individuals according to the drug of choice, age, socio-cultural 
situation and possible concomitant psychiatric and physical disorders. 
 
3.3 Establishing effective measures to reduce adverse health and social consequences 
of drug abuse; 
 Steps should be taken to reach out and engage drug users in prevention, treatment and 
care strategies that protect them, their partners and families from infectious disease, 
health problems in general, and encourage entry into substance dependence treatment 
and medical care and rehabilitation. 
 Taking into account the individual right to a healthy life and the interest of the entire 
society, specific interventions have to be promoted to reduce the adverse health and 
social consequences of drug abuse. These strategies need to target the sub-groups of the 
population that are not sensitive to prevention programmes, drug dependent individuals 
who are not motivated to attend treatment facilities, non-responders to treatment who 
continue to abuse illicit drugs, and those patients who easily relapse into substance 
abuse.  
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Recommended interventions: 
 
Services should provide non-discriminatory facilities that can reduce the harmful 
consequences of substance abuse to drug abusers.  
a. reliable information and counseling on the physical and psycho-social risks of drug 
abuse have to be provided, including information about the risk of overdose, infectious 
diseases, driving problems, cardiovascular, metabolic and psychiatric disorders; 
b. low-threshold pharmacological interventions (example opioid-agonists  and antagonist 
drugs), not directly related to drug-free oriented programmes, but to immediate health 
protection, have to be easily accessible; 
c. adequate social assistance should be provided for marginalized drug dependants; 
d. vaccination programmes against Hepatitis should be available to all drug abusers and in 
all appropriate facilities; 
e. medication and emergency kits for management of overdoses in appropriate places 
should be available; 
f. needle/syringe exchange programmes for injecting drug abusers may be implemented 
where appropriate, under sound medical practice; 
g. voluntary HIV counseling and testing, and antiretroviral treatment for HIV-infected drug 
users should be made available and accessible;  
h. prevention and services for the management of sexually transmitted infections have to 
be accessible to drug abusers and particularly to those involved in sex work; 
i. availability of measures to prevent acute consequences of stimulants abuse in the 
outlets of frequent abuse of these substances could contribute to the prevention of the 
related emergencies; 
j. interventions in emergency rooms have to be guaranteed; 
k. well-equipped street-workers and peer outreach workers units have to be adequately 
trained to contact drug abusers and dependent individuals in need of assistance. 
 
Any of the “harm reduction measures” should be in line with the provisions of the 
international drug control treaties. 
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4. The need for a comprehensive approach  
 
Prevention and treatment of substance use disorders can be considered as the initial stages of 
reducing harm, stopping or reducing drug abuse, but also countering the harmful health and 
social consequences of drug abuse. Evidence-based and comprehensive prevention and 
treatment are not incompatible with reducing the harm caused by drugs. 
 
Member States should provide both prevention/treatment opportunities and the tertiary 
prevention measures to reduce adverse health and social consequences, as part of a 
comprehensive plan. Unfortunately, due to resource limitations, some communities are not able 
to provide comprehensive programmes which take into account the real needs of drug abusers.  
 
Many substance abusers, who would be motivated to treatment but do not find accessible well-
equipped treatment facilities in their neighborhood are de facto condemned to remain in a 
condition of dependence and to perpetuate their dependence in social exclusion. Some 
countries provide only selective services and do not provide harm reduction opportunities for 
dependent individuals who are not involved in treatment. Untreated drug dependent people, 
without any contact to the health care system and welfare facilities, are exposed to the highest 
level of risk and may cause consistent harm to themselves and society as a whole. 
 
Measures to reduce adverse health and social consequences should be offered in a non-
discriminatory and comprehensive programme. If they are included in a comprehensive 
strategy, including easy access to high quality clinical facilities, drug abusers may be more 
motivated to seek treatment. 
 
“Harm reduction” measures combined with good-practice treatment facilities may prevent 
immediate adverse health and social consequences and be effective in the long-term reduction 
of drug-related harm for individuals and society. 
 
If a comprehensive strategy is not adopted, the risk of social discrimination remains high. This 
may translate into further discrimination by which marginalized drug abusers may, in the end, 
receive only some basic services (such as clean needles, condoms and occasional free food) 
while being deprived of the opportunity to have access to comprehensive treatment (such as 
out-patient and in-patient clinical facilities providing intensive care and drug-free rehabilitation 
programs). Apart from charitable organizations, such services are often provided by private 
institutions but, because of their cost, are available only to the more affluent groups. 
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Offering non-discriminatory services to drug abusers, with the aim of protecting them from the 
adverse social and health consequences of drug abuse, is not in conflict with providing 
comprehensive treatment. 
 
Provisions of appropriate evidence-based clinical services for rehabilitation of patients 
dependent on drugs who are motivated to stop drug abuse should be considered as the highest 
priority. The United Nations Drug Conventions do not accept drug abuse as an inevitable fact of 
life. UNODC specific mandate is to counteract the dramatic phenomenon of drug abuse and 
dependence that devastates the health of young people, undermines development and 
empowerment, and compromises progress and democracy. The prospective of a normal life 
with cannabis, cocaine, heroin, amphetamines and hallucinogens, legalized or not, is only an 
illusion. 
 
 
i Report of the International Narcotics Control Board for 1993 (United Nations publication, Sales No. E.94.XI.2), para.29 
  Report of the International Narcotics Control Board  for 2003 (E/INCB/2003/1), paragraphs 217  to 226  
 
ii (1) Declaration on the Guiding Principles of Demand Reduction: states that activities should cover all areas of demand reduction, from 
discouraging initial use to reducing the negative health and social consequences of drug abuse for the individual and the society as a whole. 
HIV/AIDS constitutes one of the serious potential harms of drug abuse. (2) ACC-approved UN System Position Paper: recommends a 
comprehensive package of prevention and care for IDUs, which could include  outreach services, HIV/AIDS education, condoms, drug dependency 
treatment (including substitution treatment and, where appropriate, rehabilitation), voluntary HIV testing/counseling, and psychosocial support). (3) 
June 2001 UNGASS Declaration of Commitment on HIV/AIDS: sets out general targets for Member States on HIV prevention and specific targets 
for groups with high or increasing rates of infection, including IDUs. (4) Commission on Narcotic Drugs Resolution E/CN.7/2002/L.3/Rev.1: calls 
"…upon UNODC to continue to cooperate with the Joint United Nations Programme (UNAIDS) and other relevant United Nations entities in 
introducing and strengthening programmes to address HIV/AIDS". (5) Intensifying HIV Prevention – UNAIDS Policy Position Paper: further to the 
ACC-approved UN System Position Paper, this Policy Position Paper recommends a set of measures to prevent the transmission of HIV through 
injecting drug use through the development of a comprehensive, integrated and effective system of measures that consists of the full range of 
treatment options, (notably drug substitution treatment) and the implementation of harm reduction measures (through, among others, peer 
outreach to injecting drug users, and sterile needle and syringe programmes), voluntary confidential HIV counseling and testing, prevention of 
sexual transmission of HIV among drug users (including condoms and prevention and treatment for sexually transmitted infections), access to 
primary healthcare, and access to antiretroviral therapy. Such an approach must be based on promoting, protecting and respecting the human 
rights of drug users. (6) The Joint UNAIDS statement on HIV Prevention and Care Strategies for Drug Users which acknowledges the strong and 
consistent evidence that package of harm reduction interventions significantly reduces injecting drug use and associated risk behaviours and 
hence prevents, halts and reverses HIV epidemics associated with injecting drug use. (7) Resolution/Political Declaration 60/262 on HIV/AIDS 
adopted by the General Assembly in June 2006 reiterated the urgent need to scale up significantly towards the goal of Universal Access to 
comprehensive HIV prevention programmes, treatment, care and support by 2010. 
 
 
 
